FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/26/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/26/2017     P    1000   A $0.0663   21001249   D    
Common Stock   5/26/2017     P    1000   A $0.067   21002249   D    
Common Stock   5/26/2017     P    1000   A $0.067   21003249   D    
Common Stock   5/26/2017     P    1000   A $0.067   21004249   D    
Common Stock   5/26/2017     P    1000   A $0.0665   21005249   D    
Common Stock   5/26/2017     P    1000   A $0.0665   21006249   D    
Common Stock   5/26/2017     P    1000   A $0.0665   21007249   D    
Common Stock   5/26/2017     P    1000   A $0.0668   21008249   D    
Common Stock   5/26/2017     P    1000   A $0.0668   21009249   D    
Common Stock   5/26/2017     P    1000   A $0.066   21010249   D    
Common Stock   5/26/2017     P    1000   A $0.066   21011249   D    
Common Stock   5/26/2017     P    1000   A $0.066   21012249   D    
Common Stock   5/26/2017     P    1000   A $0.066   21013249   D    
Common Stock   5/26/2017     P    1000   A $0.062   21014249   D    
Common Stock   5/26/2017     P    1000   A $0.066   21015249   D    
Common Stock   5/26/2017     P    1000   A $0.0693   21016249   D    
Common Stock   5/26/2017     P    1000   A $0.0685   21017249   D    
Common Stock   5/26/2017     P    1000   A $0.0693   21018249   D    
Common Stock   5/26/2017     P    1000   A $0.0695   21019249   D    
Common Stock   5/26/2017     P    1000   A $0.07   21020249   D    
Common Stock   5/26/2017     P    1000   A $0.068   21021249   D    
Common Stock   5/30/2017     P    1000   A $0.068   21022249   D    
Common Stock   5/30/2017     P    1000   A $0.0697   21023249   D    
Common Stock   5/30/2017     P    1000   A $0.0699   21024249   D    
Common Stock   5/30/2017     P    1000   A $0.065   21025249   D    
Common Stock   5/30/2017     P    1000   A $0.068   21026249   D    
Common Stock   5/30/2017     P    1000   A $0.0648   21027249   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 5/30/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.